Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP862472.RAuQCw3mHrWaDYCX31TnOPF1ldFz8cBfLmKw06_miS80Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP862472.RAuQCw3mHrWaDYCX31TnOPF1ldFz8cBfLmKw06_miS80Q130_assertion type Assertion NP862472.RAuQCw3mHrWaDYCX31TnOPF1ldFz8cBfLmKw06_miS80Q130_head.
- NP862472.RAuQCw3mHrWaDYCX31TnOPF1ldFz8cBfLmKw06_miS80Q130_assertion wasGeneratedBy ECO_0000203 NP862472.RAuQCw3mHrWaDYCX31TnOPF1ldFz8cBfLmKw06_miS80Q130_provenance.
- NP862472.RAuQCw3mHrWaDYCX31TnOPF1ldFz8cBfLmKw06_miS80Q130_assertion wasDerivedFrom befree-2016 NP862472.RAuQCw3mHrWaDYCX31TnOPF1ldFz8cBfLmKw06_miS80Q130_provenance.
- NP862472.RAuQCw3mHrWaDYCX31TnOPF1ldFz8cBfLmKw06_miS80Q130_assertion SIO_000772 21196304 NP862472.RAuQCw3mHrWaDYCX31TnOPF1ldFz8cBfLmKw06_miS80Q130_provenance.
- NP862472.RAuQCw3mHrWaDYCX31TnOPF1ldFz8cBfLmKw06_miS80Q130_assertion evidence source_evidence_literature NP862472.RAuQCw3mHrWaDYCX31TnOPF1ldFz8cBfLmKw06_miS80Q130_provenance.
- NP862472.RAuQCw3mHrWaDYCX31TnOPF1ldFz8cBfLmKw06_miS80Q130_assertion description "[In the present study, we found that the CD44(+)/CD24(-/low) CSCs, isolated from both human breast cell line MCF-7 and MDA-MB-231, were more resistant to thiotepa, paclitaxel and anthracycline, when compared with the non-breast cancer stem cell subset from the same cell lines, whereas the chemosensitivities were remarkably reversed by higher concentration of thiotepa and paclitaxel except for adriamycin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP862472.RAuQCw3mHrWaDYCX31TnOPF1ldFz8cBfLmKw06_miS80Q130_provenance.